Skip to main content
SpringerLink
Log in

Clinical Applications of Neuromodulation in Psychiatry

  • Chapter
  • First Online:
Textbook of Neuromodulation

Abstract

Psychiatry, as other medical specialties, currently faces challenges to enhance clinical response of different disorders. Drug refractoriness, adverse effects, elevated costs, and adherence are some of the issues that jeopardize treatment effectiveness. In this scenery, new treatment strategies such as noninvasive brain stimulation might aid to overcome such challenges. Neuromodulation techniques such as electroconvulsive therapy (ECT), transcranial magnetic stimulation (TMS), vagus nerve stimulation (VNS), transcranial direct current stimulation (tDCS), and trigeminal nerve stimulation (TNS) have been evaluated in the treatment of major psychiatric disorders with instigating results. We provide an update on traditional pharmacological approaches as well as a cutting-edge review on novel treatment strategies for some well-known incapacitating mental disorders such as major depression, bipolar depression, schizophrenia, and eating disorders. Albeit positive, current results of new therapeutical strategies need to be systematically evaluated under strict research protocols and translational research scenarios as to guarantee a feasible, widespread use of these new technologies in daily practice.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Wittchen HU, Knauper B, Kessler RC. Lifetime risk of depression. Br J Psychiatry Suppl. 1994:16–22.

    Google Scholar 

  2. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study. Lancet. 1997;349:1498–504.

    CAS  PubMed  Google Scholar 

  3. Eaton WW, Anthony JC, Gallo J, et al. Natural history of diagnostic interview schedule/DSM-IV major depression. The Baltimore Epidemiologic Catchment Area follow-up. Arch Gen Psychiatry. 1997;54:993–9.

    CAS  PubMed  Google Scholar 

  4. Rush AJ, Trivedi MH, Wisniewski SR, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry. 2006;163:1905–17.

    PubMed  Google Scholar 

  5. Cipriani A, La Ferla T, Furukawa TA, et al. Sertraline versus other antidepressive agents for depression. Cochrane Database Syst Rev. 2010;4, CD006117.

    PubMed  Google Scholar 

  6. Mendlewicz J, Massat I, Linotte S, et al. Identification of clinical factors associated with resistance to antidepressants in bipolar depression: results from an European Multicentre Study. Int Clin Psychopharmacol. 2010;25:297–301.

    PubMed  Google Scholar 

  7. Steffens D, Krishnan K, Helms M. Are SSRIs better than TCAs? Comparison of SSRIs and TCAs: a meta-analysis. Depress Anxiety. 1997;6:10–8.

    CAS  PubMed  Google Scholar 

  8. Anderson I. SSRIs versus tricyclic antidepressants in depressed inpatients: a meta-analysis of efficacy and tolerability. Depress Anxiety. 1998;7:11–7.

    PubMed  Google Scholar 

  9. Demyttenaere K. Compliance during treatment with antidepressants. J Affect Disord. 1997;43:27–39.

    CAS  PubMed  Google Scholar 

  10. Passione R. Italian psychiatry in an international context: Ugo Cerletti and the case of electroshock. Hist Psychiatry. 2004;15:83–104.

    PubMed  Google Scholar 

  11. Mankad M, Beyer J, Krystal A. Clinical manual of electroconvulsive therapy. Washington, DC: American Psychiatric Publishing; 2010.

    Google Scholar 

  12. National Institute for Health and Clinical Excellence (NICE) (2003). The clinical effectiveness and cost effectiveness of electroconvulsive Therapy (ECT) for depressive illness, schizophrenia, catatonia and mania. London: National Institute for Health and Clinical Excellence (NICE). Available online: http://www.nice.org.uk/TA059.

  13. Fleck MP, Berlim MT, Lafer B, et al. [Review of the guidelines of the Brazilian Medical Association for the treatment of depression (Complete version)]. Rev Bras Psiquiatr. 2009;31 Suppl 1:S7–17.

    PubMed  Google Scholar 

  14. Sackeim HA, Prudic J, Fuller R, Keilp J, Lavori PW, Olfson M. The cognitive effects of electroconvulsive therapy in community settings. Neuropsychopharmacology. 2007;32:244–54.

    PubMed  Google Scholar 

  15. Loo CK, Sainsbury K, Sheehan P, Lyndon B. A comparison of RUL ultrabrief pulse (0.3 ms) ECT and standard RUL ECT. Int J Neuropsychopharmacol. 2008;11:883–90.

    PubMed  Google Scholar 

  16. Loo CK, Schweitzer I, Pratt C. Recent advances in optimizing electroconvulsive therapy. Aust N Z J Psychiatry. 2006;40:632–8.

    PubMed  Google Scholar 

  17. Prudic J. Strategies to minimize cognitive side effects with ECT: aspects of ECT technique. J ECT. 2008;24:46–51.

    PubMed  Google Scholar 

  18. Brunoni AR, Teng CT, Correa C, et al. Neuromodulation approaches for the treatment of major depression: challenges and recommendations from a working group meeting. Arq Neuropsiquiatr. 2010;68:433–51.

    PubMed  Google Scholar 

  19. Pagnin D, de Queiroz V, Pini S, Cassano GB. Efficacy of ECT in depression: a meta-analytic review. J ECT. 2004;20:13–20.

    PubMed  Google Scholar 

  20. Kennedy SH, Milev R, Giacobbe P, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. IV. Neurostimulation therapies. J Affect Disord. 2009;117 Suppl 1:S44–53.

    PubMed  Google Scholar 

  21. Barker AT, Jalinous R, Freeston IL. Non-invasive magnetic stimulation of human motor cortex. Lancet. 1985;1:1106–7.

    CAS  PubMed  Google Scholar 

  22. Barrett J, Della-Maggiore V, Chouinard P, Paus T. Mechanisms of action underlying the effect of repetitive transcranial magnetic stimulation on mood: behavioral and brain imaging studies. Neuropsychopharmacology. 2004;29:1172–9.

    PubMed  Google Scholar 

  23. Videbech P. PET measurements of brain glucose metabolism and blood flow in major depressive disorder: a critical review. Acta Psychiatr Scand. 2000;101:11–20.

    CAS  PubMed  Google Scholar 

  24. O’Reardon JP, Cristancho P, Pilania P, Bapatla KB, Chuai S, Peshek AD. Patients with a major depressive episode responding to treatment with repetitive transcranial magnetic stimulation (rTMS) are resistant to the effects of rapid tryptophan depletion. Depress Anxiety. 2007;24:537–44.

    PubMed  Google Scholar 

  25. George MS, Aston-Jones G. Noninvasive techniques for probing neurocircuitry and treating illness: vagus nerve stimulation (VNS), transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS). Neuropsychopharmacology. 2010;35:301–16.

    PubMed Central  PubMed  Google Scholar 

  26. Schutter DJ. Antidepressant efficacy of high-frequency transcranial magnetic stimulation over the left dorsolateral prefrontal cortex in double-blind sham-controlled designs: a meta-analysis. Psychol Med. 2009;39:65–75.

    CAS  PubMed  Google Scholar 

  27. Schutter DJ. Quantitative review of the efficacy of slow-frequency magnetic brain stimulation in major depressive disorder. Psychol Med. 2010;40:1789–95.

    CAS  PubMed  Google Scholar 

  28. Slotema CW, Blom JD, Hoek HW, Sommer IE. Should we expand the toolbox of psychiatric treatment methods to include repetitive transcranial magnetic stimulation (rTMS)? A meta-analysis of the efficacy of rTMS in psychiatric disorders. J Clin Psychiatry. 2010;71:873–84.

    PubMed  Google Scholar 

  29. Cohen RB, Boggio PS, Fregni F. Risk factors for relapse after remission with repetitive transcranial magnetic stimulation for the treatment of depression. Depress Anxiety. 2009;26:682–8.

    PubMed  Google Scholar 

  30. Demirtas-Tatlidede A, Mechanic-Hamilton D, Press DZ, et al. An open-label, prospective study of repetitive transcranial magnetic stimulation (rTMS) in the long-term treatment of refractory depression: reproducibility and duration of the antidepressant effect in medication-free patients. J Clin Psychiatry. 2008;69:930–4.

    PubMed  Google Scholar 

  31. Fitzgerald PB, Benitez J, de Castella AR, Brown TL, Daskalakis ZJ, Kulkarni J. Naturalistic study of the use of transcranial magnetic stimulation in the treatment of depressive relapse. Aust N Z J Psychiatry. 2006;40:764–8.

    PubMed  Google Scholar 

  32. O’Reardon J, Peshek A, Romero R. Neuromodulation and transcranial magnetic stimulation (TMS): a 21st century paradigm for therapeutics in psychiatry. Psychiatry. 2005;3:30–40.

    Google Scholar 

  33. Rossi S. The safety of TMS consensus group. Clin Neurophysiol. 2009;120:2008–39.

    PubMed Central  PubMed  Google Scholar 

  34. Xia G, Gajwani P, Muzina DJ, et al. Treatment-emergent mania in unipolar and bipolar depression: focus on repetitive transcranial magnetic stimulation. Int J Neuropsychopharmacol. 2008;11:119–30.

    PubMed  Google Scholar 

  35. Simpson KN, Welch MJ, Kozel FA, Demitrack MA, Nahas Z. Cost-effectiveness of transcranial magnetic stimulation in the treatment of major depression: a health economics analysis. Adv Ther. 2009;26:737.

    Google Scholar 

  36. Brunoni AR, Nitsche MA, Bolognini N, et al. Clinical research with transcranial direct current stimulation (tDCS): challenges and future directions. Brain Stimul. 2012;5(3):175–95.

    PubMed Central  PubMed  Google Scholar 

  37. Fregni F, Boggio PS, Nitsche MA, Marcolin MA, Rigonatti SP, Pascual-Leone A. Treatment of major depression with transcranial direct current stimulation. Bipolar Disord. 2006;8:203–4.

    PubMed  Google Scholar 

  38. Fregni F, Boggio PS, Nitsche MA, Rigonatti SP, Pascual-Leone A. Cognitive effects of repeated sessions of transcranial direct current stimulation in patients with depression. Depress Anxiety. 2006;23:482–4.

    PubMed  Google Scholar 

  39. Rigonatti SP, Boggio PS, Myczkowski ML, et al. Transcranial direct stimulation and fluoxetine for the treatment of depression. Eur Psychiatry. 2008;23:74–6.

    PubMed  Google Scholar 

  40. Boggio PS, Rigonatti SP, Ribeiro RB, et al. A randomized, double-blind clinical trial on the efficacy of cortical direct current stimulation for the treatment of major depression. Int J Neuropsychopharmacol. 2008;11:249–54.

    PubMed Central  PubMed  Google Scholar 

  41. Loo CK, Sachdev P, Martin D, et al. A double-blind, sham-controlled trial of transcranial direct current stimulation for the treatment of depression. Int J Neuropsychopharmacol. 2010;13:61–9.

    PubMed  Google Scholar 

  42. Ferrucci R, Bortolomasi M, Brunoni AR, et al. Comparative benefits of transcranial direct current stimulation (tDCS) treatment in patients with mild/moderate vs. severe depression. Clin Neuropsychiatry. 2009;6:246–51.

    Google Scholar 

  43. Brunoni AR, Ferrucci R, Bortolomasi M, et al. Transcranial direct current stimulation (tDCS) in unipolar vs. bipolar depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2011;35:96–101.

    CAS  PubMed  Google Scholar 

  44. Dell’osso B, Zanoni S, Ferrucci R, et al. Transcranial direct current stimulation for the outpatient treatment of poor-responder depressed patients. Eur Psychiatry. 2011;27(7):513–7.

    PubMed  Google Scholar 

  45. Martin D, Alonzo A, Mitchell P, Sachdev P, Galvez V, Loo C. Fronto-extracephalic transcranial direct current stimulation as a treatment for major depression: an open-label pilot study. J Affect Disord. 2011;134:459–63.

    PubMed  Google Scholar 

  46. Kalu UG, Sexton CE, Loo CK, Ebmeier KP. Transcranial direct current stimulation in the treatment of major depression: a meta-analysis. Psychol Med. 2012;42:1791–800.

    CAS  PubMed  Google Scholar 

  47. Mohr P, Rodriguez M, Slavickova A, Hanka J. The application of vagus nerve stimulation and deep brain stimulation in depression. Neuropsychobiology. 2011;64:170–81.

    PubMed  Google Scholar 

  48. Holtzheimer PE, Kelley ME, Gross RE, et al. Subcallosal cingulate deep brain stimulation for treatment-resistant unipolar and bipolar depression. Arch Gen Psychiatry. 2012;69:150–8.

    PubMed  Google Scholar 

  49. Mayberg HS, Lozano AM, Voon V, et al. Deep brain stimulation for treatment-resistant depression. Neuron. 2005;45:651–60.

    CAS  PubMed  Google Scholar 

  50. Kennedy SH, Giacobbe P, Rizvi SJ, Placenza FM, Nishikawa Y, Mayberg HS, Lozano AM. Deep brain stimulation for treatment-resistant depression: follow-up after 3 to 6 years. Am J Psychiatry. 2011;168:502–10.

    PubMed  Google Scholar 

  51. Bajbouj M, Merkl A, Schlaepfer TE, et al. Two-year outcome of vagus nerve stimulation in treatment-resistant depression. J Clin Psychopharmacol. 2010;30:273–81.

    PubMed  Google Scholar 

  52. Gerson R, Murray E, Price B, Frankel M, Douglass L, Cunningham M. Mania following vagus nerve stimulation: a case report and review of the literature. Epilepsy Behav. 2011;20:138–40.

    PubMed  Google Scholar 

  53. Biermann T, Kreil S, Groemer T, et al. Time perception in patients with major depressive disorder during vagus nerve stimulation. Pharmacopsychiatry. 2011;44:179–82.

    CAS  PubMed  Google Scholar 

  54. Sperling W, Biermann T, Spannenberger R, et al. Changes in gustatory perceptions of patients with major depression treated with vagus nerve stimulation (VNS). Pharmacopsychiatry. 2011;44:67–71.

    CAS  PubMed  Google Scholar 

  55. Schrader L, Cook I, Miller P, Maremont E, DeGiorgi OC. Trigeminal nerve stimulation in major depressive disorder: first proof of concept in an open pilot trial. Epilepsy Behav. 2011;22:475–8.

    PubMed  Google Scholar 

  56. Yatham LN, Kennedy SH, Schaffer A, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. Bipolar Disord. 2009;11:225–55.

    CAS  PubMed  Google Scholar 

  57. Mendels J, Frazer A. Intracellular lithium concentration and clinical response: towards a membrane theory of depression. J Psychiatr Res. 1973;10:9–18.

    CAS  PubMed  Google Scholar 

  58. Goodwin FK, Murphy DL, Bunney WE. Lithium-carbonate treatment in depression and mania—a longitudinal double-blind study. Arch Gen Psychiatry. 1969;21:486–96.

    CAS  PubMed  Google Scholar 

  59. Greenspan K, Schildkraut J, Gordon E, Baer L, Aronoff M, Durell J. Catecholamine metabolism in affective disorder—III: MHPG and other catecholamine metabolites in patients treated with lithium carbonate. J Psychiatr Res. 1970;7:171–83.

    CAS  PubMed  Google Scholar 

  60. Baron M, Gershon E, Rudy V, Jonas W, Buchsbaum M. Lithium carbonate response in depression. Arch Gen Psychiatry. 1975;32:1107–11.

    CAS  PubMed  Google Scholar 

  61. Srisurapanont M, Yatham L, Zis A. Treatment of acute bipolar depression: a review of the literature. Can J Psychiatry. 1995;40:533–44.

    CAS  PubMed  Google Scholar 

  62. Dolberg OT, Dannon PN, Schreiber S, Grunhaus L. Transcranial magnetic stimulation in patients with bipolar depression: a double blind, controlled study. Bipolar Disord. 2002;4 Suppl 1:94–5.

    PubMed  Google Scholar 

  63. Nahas Z, Kozel FA, Li X, Anderson B, George MS. Left prefrontal transcranial magnetic stimulation (TMS) treatment of depression in bipolar affective disorder: a pilot study of acute safety and efficacy. Bipolar Disord. 2003;5:40–7.

    PubMed  Google Scholar 

  64. Tamas RL, Menkes D, El-Mallakh RS. Stimulating research: a prospective, randomized, double-blind, sham-controlled study of slow transcranial magnetic stimulation in depressed bipolar patients. J Neuropsychiatry Clin Neurosci. 2007;19:198–9.

    PubMed  Google Scholar 

  65. Dell’Osso B, Mundo E, D’Urso N, et al. Augmentative repetitive navigated transcranial magnetic stimulation (rTMS) in drug-resistant bipolar depression. Bipolar Disord. 2009;11:76–81.

    PubMed  Google Scholar 

  66. Grisaru N, Chudakov B, Yaroslavsky Y, Belmaker RH. Transcranial magnetic stimulation in mania: a controlled study. Am J Psychiatry. 1998;155:1608–10.

    CAS  PubMed  Google Scholar 

  67. Michael N, Erfurth A. Treatment of bipolar mania with right prefrontal rapid transcranial magnetic stimulation. J Affect Disord. 2004;78:253–7.

    PubMed  Google Scholar 

  68. Saba G, Rocamora JF, Kalalou K, et al. Repetitive transcranial magnetic stimulation as an add-on therapy in the treatment of mania: a case series of eight patients. Psychiatry Res. 2004;128:199–202.

    PubMed  Google Scholar 

  69. Praharaj S, Ram D, Arora M. Efficacy of high frequency (rapid) suprathreshold repetitive transcranial magnetic stimulation of right prefrontal cortex in bipolar mania: a randomized sham controlled study. J Affect Disord. 2009;117:146–50.

    PubMed  Google Scholar 

  70. Loranger A. Sex difference in age at onset of schizophrenia. Arch Gen Psychiatry. 1984;41:157–61.

    CAS  PubMed  Google Scholar 

  71. McGlashan T, Johannessen J. Early detection and intervention with schizophrenia: rationale. Schizophr Bull. 1996;22:201–22.

    CAS  PubMed  Google Scholar 

  72. Andreasen N. Symptoms, signs, and diagnosis of schizophrenia. Lancet. 1995;346:477–81.

    CAS  PubMed  Google Scholar 

  73. Wong A, Van Tol H. Schizophrenia: from phenomenology to neurobiology. Neurosci Biobehav Rev. 2003;27:269–306.

    PubMed  Google Scholar 

  74. APA. Diagnostic and statistic manual of mental disorders, IV-TR ed. Washington, DC: American Psychiatric Association; 2000.

    Google Scholar 

  75. Weickert T, Goldberg T, Gold J, Bigelow L, Egan M. Cognitive impairments in patients with schizophrenia displaying preserved and compromised intellect. Arch Gen Psychiatry. 2000;57:907–13.

    CAS  PubMed  Google Scholar 

  76. Conley R. The burden of depressive symptoms in people with schizophrenia. Psychiatr Clin North Am. 2009;32:853–61.

    PubMed  Google Scholar 

  77. Bensenor I, Brunoni A, Pilan L, Goulart A, Busatto G. Cardiovascular risk factors in patients with first-episode psychosis in Sao Paulo, Brazil. Gen Hosp Psychiatry. 2012;34:268–75.

    PubMed  Google Scholar 

  78. Bressan R, Chaves A, Pilowsky L, Shirakawa I, Mari J. Depressive episodes in stable schizophrenia: critical evaluation of the DSM-IV and ICD-10 diagnostic criteria. Psychiatry Res. 2003;117:47–56.

    PubMed  Google Scholar 

  79. Lieberman J, Stroup T, McEvoy J, Swartz M, Rosenheck R. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med. 2005;353:1209–23.

    CAS  PubMed  Google Scholar 

  80. Jones P, Barnes T, Davies L, Dunn G, Lloyd H. Randomized controlled trial of the effect on quality of life of second- vs. first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1). Arch Gen Psychiatry. 2006;63:1079–87.

    CAS  PubMed  Google Scholar 

  81. Davis J, Chen N, Glick I. A meta-analysis of the efficacy of second-generation antipsychotics. Arch Gen Psychiatry. 2003;60:553–64.

    CAS  PubMed  Google Scholar 

  82. Elkis H, Louza M. Psiquiatria Básica. 2nd ed. São Paulo: Atheneu; 2007.

    Google Scholar 

  83. Chong S, Remington G. Clozapine augmentation: safety and efficacy. Schizophr Bull. 2000;26:421–40.

    CAS  PubMed  Google Scholar 

  84. Taylor D, Paton C, Kapur S. The South London and Maudsley NHS Foundation Trust and Oxleas NHS Foundation Trust: prescribing guidelines. 10th ed. London: Informa Healthcare; 2009.

    Google Scholar 

  85. Tharyan P, Adams CE. Electroconvulsive therapy for schizophrenia. Cochrane Database Syst Rev. 2005 Apr 18;(2):CD000076. Review.

    Google Scholar 

  86. Kho K, Blansjaar B, de Vries S, Babuskova D, Zwinderman AH, et al. Electroconvulsive therapy for the treatment of clozapine nonresponders suffering from schizophrenia—an open label study. Eur Arch Psychiatry Clin Neurosci. 2004;254:372–9.

    CAS  PubMed  Google Scholar 

  87. Chanpattana W. (2007). A questionnaire survey of ECT practice in Australia. Journal of ECT 23(2):89-92.

    Google Scholar 

  88. Burt T, Lisanby SH, Sackeim HA. Neuropsychiatric applications of transcranial magnetic stimulation: a meta analysis. Int J Neuropsychopharmacol. 2002;5:73–103.

    PubMed  Google Scholar 

  89. Hoffman RE, Boutros NN, Berman RM, et al. Transcranial magnetic stimulation of left temporoparietal cortex in three patients reporting hallucinated “voices”. Biol Psychiatry. 1999;46:130–2.

    CAS  PubMed  Google Scholar 

  90. d’Alfonso AA, Aleman A, Kessels RP, et al. Transcranial magnetic stimulation of left auditory cortex in patients with schizophrenia: effects on hallucinations and neurocognition. J Neuropsychiatry Clin Neurosci. 2002;14:77–9.

    PubMed  Google Scholar 

  91. Hoffman RE, Hawkins KA, Gueorguieva R, et al. Transcranial magnetic stimulation of left temporoparietal cortex and medication-resistant auditory hallucinations. Arch Gen Psychiatry. 2003;60:49–56.

    PubMed  Google Scholar 

  92. Cohen E, Bernardo M, Masana J, et al. Repetitive transcranial magnetic stimulation in the treatment of chronic negative schizophrenia: a pilot study. J Neurol Neurosurg Psychiatry. 1999;67:129–30.

    CAS  PubMed Central  PubMed  Google Scholar 

  93. Dlabac-de-Lange J, Knegtering R, Aleman A. Repetitive transcranial magnetic stimulation for negative symptoms of schizophrenia: review and meta-analysis. J Clin Psychiatry. 2010;71:411–8.

    PubMed  Google Scholar 

  94. Brunelin J, Mondino M, Gassab L, et al. Examining transcranial direct-current stimulation (tDCS) as a treatment for hallucinations in schizophrenia. Am J Psychiatry. 2012;169(7):719–24.

    PubMed  Google Scholar 

  95. Berkman N, Bulik C, Brownley K. Management of eating disorders. Evid Rep Technol Assess. 2006;135:1–166.

    Google Scholar 

  96. Attia E, Haiman C, Walsh B, Flater S. Does fluoxetine augment the inpatient treatment of anorexia nervosa? Am J Psychiatry. 1998;155:548–51.

    CAS  PubMed  Google Scholar 

  97. Kaye W, Nagata T, Weltzin T. Double-blind placebo-controlled administration of fluoxetine in restricting- and restricting-purging-type anorexia nervosa. Biol Psychiatry. 2001;49:644–52.

    CAS  PubMed  Google Scholar 

  98. Fassino S, Leombruni P, Daga G. Efficacy of citalopram in anorexia nervosa: a pilot study. Eur Neuropsychopharm. 2002;12:453–9.

    CAS  Google Scholar 

  99. Brown T, Keel P. Current and emerging directions in the treatment of eating disorders. Subst Abuse. 2012;6:33–61.

    CAS  PubMed Central  PubMed  Google Scholar 

  100. Herpertz S, Hagenah U, Vocks S, von Wietersheim J, Cuntz U, Zeeck A. The diagnosis and treatment of eating disorders. Dtsch Arztebl Int. 2011;108:678–85.

    PubMed Central  PubMed  Google Scholar 

  101. Treasure J, Tchanturia K, Schmidt U. Developing a model of the treatment for eating disorder: using neuroscience research to examine the how rather than the what of change. Couns Psychother Res. 2005;5:191–202.

    Google Scholar 

  102. Hudson J, Pope HJ, Jonas J, Yurgelun-Todd D. Family history study of anorexia nervosa and bulimia. Br J Psychiatry. 1983;142:428–9.

    CAS  PubMed  Google Scholar 

  103. Milano W, Siano C, Putrella C, Capasso A. Treatment of bulimia nervosa with fluvoxamine: a randomized controlled trial. Adv Ther. 2005;22:278–83.

    CAS  PubMed  Google Scholar 

  104. Fichter M, Kruger R, Rief W, Holland R, Dohne J. Fluvoxamine in prevention of relapse in bulimia nervosa: effects on eating-specific psychopathology. J Clin Psychopharmacol. 1996;16:9–18.

    CAS  PubMed  Google Scholar 

  105. Milano W, Petrella C, Sabatino C, Capasso A. Treatment of bulimia nervosa with sertraline: a randomized controlled trial. Adv Ther. 2004;21:232–7.

    CAS  PubMed  Google Scholar 

  106. Karno M, Golding J, Sorenson S, Burnam M. The epidemiology of obsessive compulsive disorder in five US communities. Arch Gen Psychiatry. 1988;45:1094–9.

    CAS  PubMed  Google Scholar 

  107. Weissman M, Bland R, Canino G, Greenwald S, Hwu H, Lee C. The cross national epidemiology of obsessive compulsive disorder. J Clin Psychiatry. 1994;55:5–10.

    PubMed  Google Scholar 

  108. Iancu I, Dannon P, Zohar J. Obsessive–compulsive disorder. Oxford: Oxford University Press; 2003.

    Google Scholar 

  109. Shin M, Choi H, Kim H, Hwang J, Kim B, Cho S. A study of neuropsychological deficit in children with obsessive-compulsive disorder. Eur Psychiatry. 2008;23:512–20.

    PubMed  Google Scholar 

  110. March J, Mulle K. OCD in children and adolescents: a Cognitive behavioral treatment manual. New York: The Guilford Press; 1998.

    Google Scholar 

  111. Watson H, Rees C. Meta-analysis of randomized, controlled treatment trials for pediatric obsessive-compulsive disorder. J Child Psychol Psychiatry. 2008;49:489–98.

    PubMed  Google Scholar 

  112. Sachdev P, Loo C, Mitchell P, McFarquhar T, Malhi G. Repetitive transcranial magnetic stimulation for the treatment of obsessive compulsive disorder: a double blind controlled investigation. Psychol Med. 2007;37:1645–9.

    PubMed  Google Scholar 

  113. Nauczyciel C, Drapier D. Repetitive transcranial magnetic stimulation in the treatment of obsessive-compulsive disorder. Rev Neurol (Paris). 2012;168:655–61.

    CAS  Google Scholar 

  114. Volpato C, Piccione F, Cavinato M, et al. Modulation of affective symptoms and resting state activity by brain stimulation in a treatment-resistant case of obsessive-compulsive disorder. Neurocase. 2013;19(4):360–70.

    CAS  PubMed  Google Scholar 

  115. Barkley R. Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD. Psychol Bull. 1997;121:65–94.

    CAS  PubMed  Google Scholar 

  116. Swanson M, Kraemer C, Hinshaw P, Arnold E, Conners K, Abikoff B. Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment. J Am Acad Child Psychiatry. 2001;40:168–79.

    CAS  Google Scholar 

  117. Kujirai T, Caramia M, Rothwell J, et al. Corticocortical inhibition in human motor cortex. J Physiol. 1993;471:501–19.

    CAS  PubMed Central  PubMed  Google Scholar 

  118. Moll G, Heinrich H, Rothenberger A. Transcranial magnetic stimulation in child and adolescent psychiatry: excitability of the motor system in tic disorders and/or attention deficit hyperactivity disorders. Z Kinder Jugendpsychiatr Psychother. 2001;29:312–23.

    CAS  PubMed  Google Scholar 

  119. Weaver L, Rostain A, Mace W, Akhtar U, Moss E, O’Reardon J. Transcranial magnetic stimulation (TMS) in the treatment of attention-deficit/hyperactivity disorder in adolescents and young adults: a pilot study. J ECT. 2012;28:98–103.

    PubMed  Google Scholar 

  120. Niederhofer H. Effectiveness of the repetitive transcranical magnetic stimulation (rTMS) of 1 Hz for attention- deficit hyperactivity disorder (ADHD). Psychiatr Danub. 2008;20:91–2.

    PubMed  Google Scholar 

  121. Bloch Y, Harel E, Aviram S. Positive effects of repetitive transcranial magnetic stimulation on attention in ADHD subjects: a randomized controlled pilot study. World J Biol Psychiatry. 2010;11:755–8.

    CAS  PubMed  Google Scholar 

  122. APA. Diagnostic and statistical manual of mental disorders DSM-IV-TR. 4th ed. Washington, DC: American Psychiatric Publishing; 2000.

    Google Scholar 

  123. Huang C, Wei I, Chou Y, Su T. Effect of age, gender, menopausal status, and ovarian hormonal level on rTMS in treatment-resistant depression. Psychoneuroendocrinology. 2008;33:821–31.

    PubMed  Google Scholar 

  124. Walpoth M, Hoertnagl C, Mangweth-Matzek B, et al. Repetitive transcranial magnetic stimulation in bulimia nervosa: preliminary results of a single-centre, randomised, double-blind, sham-controlled trial in female outpatients. Psychother Psychosom. 2008;77:57–60.

    CAS  PubMed  Google Scholar 

  125. Van den Eynde F, Claudino A, Mogg A, et al. Repetitive transcranial magnetic stimulation reduces cue-induced food craving in bulimic disorders. Biol Psychiatry. 2010;67:793–5.

    PubMed  Google Scholar 

  126. Van den Eynde F, Claudino A, Campbell I, Schmidt U. Immediate cognitive effects of repetitive transcranial magnetic stimulation in eating disorders: a pilot study. Eat Weight Disord. 2011;16:45–8.

    Google Scholar 

  127. Claudino AM, Van den Eynde F, Stahl D, et al. Repetitive transcranial magnetic stimulation reduces cortisol concentrations in bulimic disorders. Psychol Med. 2011;41:1329–36.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratory of Clinical Neuromodulation, Santa Casa Medical School, 1 Rua Major Magliano 241, Sao Paulo, Brazil

    Pedro Shiozawa

  2. Department of Psychiatry, Santa Casa Medical School, São Paulo, Brazil

    Rosamaria Raza & Quirino Cordeiro Jr.

  3. Department and Institute of Psychiatry, University of São Paulo, São Paulo, Brazil

    André Russowsky Brunoni

Authors
  1. Pedro Shiozawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rosamaria Raza
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Quirino Cordeiro Jr.
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. André Russowsky Brunoni
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Pedro Shiozawa .

Editor information

Editors and Affiliations

  1. Institute for Innovation in Palliative Care, Metropolitan Jewish Health Systems (MJHS), New York, New York, USA

    Helena Knotkova

  2. University of Lübeck, Department of Neurosurgery University Hospital of Schleswig-Holstein, Lübeck, Germany

    Dirk Rasche

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Shiozawa, P., Raza, R., Cordeiro, Q., Brunoni, A.R. (2015). Clinical Applications of Neuromodulation in Psychiatry. In: Knotkova, H., Rasche, D. (eds) Textbook of Neuromodulation. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-1408-1_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-1408-1_14

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-1407-4

  • Online ISBN: 978-1-4939-1408-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation